Eam Investors, LLC Catalyst Biosciences, Inc. Transaction History

Eam Investors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 03, 2018	SELL	$9.11 - $28.88 $332,123 - $1.05 Million	-36,457 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$14.18 - $35.6 $516,960 - $1.3 Million	36,457 New	36,457 $941,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.